Zenas BioPharma, Inc. (ZBIO)
NASDAQ: ZBIO · Real-Time Price · USD
22.88
+1.12 (5.15%)
Oct 6, 2025, 3:54 PM EDT - Market open
Zenas BioPharma Market Cap
Zenas BioPharma has a market cap or net worth of $963.48 million as of October 6, 2025. Its market cap has increased by 35.27% in one year.
Market Cap
963.48M
Enterprise Value
722.37M
1-Year Change
35.27%
Ranking
Category
Stock Price
$22.88
Market Cap Chart
Since the IPO on September 13, 2024, Zenas BioPharma's market cap has increased from $676.47M to $963.48M, an increase of 42.43%. That is a compound annual growth rate of 39.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 3, 2025 | 916.32M | 167.72% |
| Dec 31, 2024 | 342.27M | -49.40% |
| Sep 13, 2024 | 676.47M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 753.98B |
| Johnson & Johnson | 454.31B |
| AbbVie | 413.22B |
| UnitedHealth Group | 326.22B |
| Novo Nordisk | 264.73B |
| AstraZeneca | 264.35B |
| Novartis AG | 256.18B |
| Abbott Laboratories | 234.25B |